Non-GLP Toxicology Studies

After drug discovery, the next stage in the development pipeline involves generating safety data to progress into First-in-Human studies. Non-GLP toxicology studies, which precede GLP studies required for an IND submission, are conducted to assess risks, dosing, and other critical factors essential for in vivo testing.

This service overview presents Pharmaron’s capabilities for efficiently generating robust non-GLP data to assess the safety of test articles.